Abstract
The search for an effective vaccine against malaria caused by Plasmodium vivax is one of the main goals of global research and will likely require a product that includes several antigens from the parasite cycle. To achieve this goal, we propose to develop a multi-antigen and multi-stage vaccine capable of preventing infection and / or clinical manifestations of malaria vivax. Thus, we pr…